ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Motif Bio plc
0.1050
0.0000
成交量:
- -
成交額:
- -
市值:
5,096.69萬
市盈率:
-2.17
高:
0.1050
開:
0.1050
低:
0.1050
收:
0.1050
52周最高:
11.50
52周最低:
0.0750
股本:
4.85億
流通股本:
4.83億
量比:
- -
換手率:
- -
股息:
- -
股息率:
- -
每股收益(TTM):
-0.0483
每股收益(LYR):
-0.0492
淨資產收益率:
170.83%
總資產收益率:
-53.86%
市淨率:
-5.71
市盈率(LYR):
-2.14
資料載入中...
總覽
公司
新聞資訊
公告
公司資料
公司名字:
Motif Bio plc
交易所:
NASDAQ
成立時間:
- -
員工人數:
- -
公司地址:
- -
官網:
http://www.motifbio.com
郵編:
- -
電話:
- -
傳真:
- -
簡介:
Motif Bio plc在英格蘭和威爾士註冊成立於2014年11月20日,為了在AIM首次公開發行的目的,並成為在特拉華州註冊成立於2003年12月2日的Motif BioSciences公司的控股公司,在歷史上通過它們開展業務。他們是一家臨床階段的生物製藥公司,從事旨在對抗引起多重耐藥細菌住院患者嚴重和危及生命的感染有效的新抗生素的研發。
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/MTFB/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MTFB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MTFB\",,,,,undefined,":{"symbol":"MTFB","market":"US","secType":"STK","nameCN":"Motif Bio plc","latestPrice":0.105011,"timestamp":1577826000000,"preClose":0.105011,"halted":4,"volume":0,"delay":0,"changeRate":0,"floatShares":482768055,"shares":485348166,"eps":-0.048292,"marketStatus":"退市","change":0,"latestTime":"12-31 16:00:00 EST","open":0.105011,"high":0.105011,"low":0.105011,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.048292,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1773648000000},"marketStatusCode":7,"adr":1,"adrRate":20,"listingDate":1479445200000,"exchange":"NASDAQ","adjPreClose":0.105011,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MTFB\",,,,,undefined,":{"symbol":"MTFB","floatShares":482768055,"roa":"-53.86%","roe":"170.83%","lyrEps":-0.049151,"shares":485348166,"dividePrice":0,"high":0.105011,"amplitude":0,"preClose":0.105011,"low":0.105011,"week52Low":0.075,"pbRate":"-5.71","week52High":11.4999,"institutionHeld":0,"latestPrice":0.105011,"eps":-0.048292,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.048292,"open":0.105011},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MTFB\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MTFB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MTFB\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.motifbio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.015},{"period":"1month","weight":-0.0429},{"period":"3month","weight":-0.0286},{"period":"6month","weight":0.0074},{"period":"1year","weight":0.2011},{"period":"ytd","weight":-0.0288}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Motif Bio plc在英格蘭和威爾士註冊成立於2014年11月20日,為了在AIM首次公開發行的目的,並成為在特拉華州註冊成立於2003年12月2日的Motif BioSciences公司的控股公司,在歷史上通過它們開展業務。他們是一家臨床階段的生物製藥公司,從事旨在對抗引起多重耐藥細菌住院患者嚴重和危及生命的感染有效的新抗生素的研發。","exchange":"NASDAQ","name":"Motif Bio plc","nameEN":"Motif Bio plc"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"MTFB\",market:\"US\",,,undefined,":null}}